Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression

Paul Hoover(Brigham and Women's Hospital), Thomas Eisenhaure(Broad Institute), Jeffrey Hodgin(University of Michigan), William Apruzzese(Brigham and Women's Hospital), Joseph Mears(Brigham and Women's Hospital), Michael Peters(Broad Institute), Tony Jones(Broad Institute), Sujal I. Shah(Brigham and Women's Hospital), Haniya Kamal(Brigham and Women's Hospital), Rollin Leavitt(Broad Institute), Shaun W. Jackson, Patrick Danaher(Bruker (United States)), Deepak A. Rao(Brigham and Women's Hospital), Qian Xiao(Brigham and Women's Hospital), Siddarth Gurajala(Brigham and Women's Hospital), Andrea Fava(Johns Hopkins University), Céline C. Berthier(University of Michigan), Alice Horisberger(Brigham and Women's Hospital), Peter Izmirly(New York University), H. Michael Belmont(New York University), Robert Clancy(New York University), Richard Furie(Feinstein Institute for Medical Research), Joel M. Guthridge(Oklahoma Medical Research Foundation), Maria Dall'Era, David Wofsy(University of California, San Francisco), Diane L Kamen(Medical University of South Carolina), Kenneth Kalunian(University of California San Diego), Maureen McMahon(University of California, Los Angeles), Jennifer Grossman(University of California, Los Angeles), Fernanda Payan‐Schober(Texas Tech University), D. Hildeman(Cincinnati Children's Hospital Medical Center), E Steve Woodle(University of Cincinnati Medical Center), Chaim Putterman(Albert Einstein College of Medicine), M Kretzler(University of Michigan), Soumya Raychaudhuri(Brigham and Women's Hospital), Judith A James(Oklahoma Medical Research Foundation), Jennifer H. Anolik(University of Rochester), Michelle A Petri, J Buyon(New York University), the Accelerating Medicines Partnership (AMP) RA/SLE Network, Betty Diamond(Feinstein Institute for Medical Research), A Davidson(Feinstein Institute for Medical Research), N. Hacohen(Broad Institute), Arnon Arazi(Feinstein Institute for Medical Research)
bioRxiv (Cold Spring Harbor Laboratory)
December 19, 2025
Cited by 0Open Access
Full Text

Abstract

ABSTRACT Objectives Lupus nephritis (LN) is a common, potentially fatal manifestation of systemic lupus erythematosus. We aim to gain new insights into the immune responses underlying LN and their relation to the histologic heterogeneity observed in this disease, focusing on myeloid cells. Methods Single-cell RNA-sequencing (scRNA-seq) was used to profile dissociated kidney samples from 156 LN patients and 30 healthy individuals. Spatial transcriptomics (ST), utilizing a gene panel designed to capture all myeloid subsets identified in the scRNA-seq data, was applied to kidney samples acquired from 6 LN patients and 2 healthy controls. Results We generated a full catalog of the myeloid subsets found in LN kidneys. Our analyses indicated that an increase in irreversible tissue damage, as measured by the NIH chronicity index (CI), is associated with a gradual switch of the local immune response from one dominated by monocytes and macrophages to one featuring expanded CD4 + T, GZMK + CD8 + T, B and dendritic cells, with a parallel decrease in the interferon response. In proliferative/mixed LN only, the degree of active inflammation correlates with expansion of disease-specific macrophage (DMac) subsets, which later contract as the CI increases. Trajectory analysis of the scRNA-seq data suggested that DMacs arise from both infiltrating monocytes and tissue-resident macrophages; this was supported by the ST data, as well as cell cultures. DMacs are indicated to interact with parietal epithelial cells, promoting the development of glomerulosclerosis. Conclusions We suggest a detailed picture of the changes in the kidney immune mechanisms in LN as this disease progresses.


Related Papers

No related papers found

Powered by citation graph analysis